/BLFS

BioLife Solutions Inc

BLFS

$34.95USD↑+0.09%+0.03 today

MARKET CAP

1.7B

P/E (TTM)

120.4x

FWD P/E

127.2x

DAY RANGE

$35 – $35

52W RANGE

$18

$38

AI Summary

Stalk

Sell NowMedium

Recent decisive support failure on elevated volume and sliding below the 9EMA and 20EMA has shifted the medium-term bias bearish, despite the intact long-term uptrend. Short-term conditions remain unfavorable for buyers with no reversal patterns, so the preferred execution is to sell into any relief rallies around the broken support-turned-resistance near the 9/20 EMAs.

↑Q2 revenue $28.5 M (+21% YoY) with GAAP net income $45.1 M
↑Adjusted EBITDA $7.4 M (26% margin) and 64% GAAP gross margin
↓Key customers drive majority of sales, raising concentration risk

Full analysis →

Buying

7

institutions

Selling

5

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
TR T. Rowe Price Investment Management, Inc. Q2 2026	BUY	6.75 M	190.65 M	+244.79 K	+53.6%	0.13%
BI Blackrock, Inc. Q2 2026	BUY	6.38 M	180.05 M	+273.78 K	+54.6%	0.00%
CC Casdin Capital, LLC Q2 2026	SELL	4.66 M	131.46 M	+-1.30 M	+15.7%	6.58%
MM Millennium Management LLC Q2 2026	BUYNEW	675.66 K	19.08 M	+675.66 K	+0.0%	0.01%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	445.02 K	12.57 M	+-296.33 K	-11.2%	0.02%
JC Jpmorgan Chase & Co Q2 2026	SELL	230.23 K	6.52 M	+-2.47 K	+49.1%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	193.74 K	5.47 M	+-50.43 K	+17.4%	0.00%
MG Man Group Plc Q2 2026	BUY	145.50 K	4.11 M	+72.88 K	+196.5%	0.01%
PA Point72 Asset Management, L.P. Q2 2026	BUYNEW	35.02 K	988.94 K	+35.02 K	+0.0%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	39.43 K	752.80 K	+19.72 K	+58.0%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUYNEW	15.74 K	444.47 K	+15.74 K	+0.0%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	0.00	0.00	+-207.13 K	-100.0%	0.00%